ストックスクリーナーアプリを入手
37.72
1.59%
-0.61
アフターアワーズ：
37.71
-0.010
-0.03%
前日終値:
$38.33
開ける：
$38.24
24時間の取引高:
38,647
Relative Volume:
0.88
時価総額：
$148.57M
収益：
$17,000
当期純損益:
$-31.08M
株価収益率:
-11.27
EPS:
-3.3463
ネットキャッシュフロー:
$-24.86M
1週間 パフォーマンス:
-1.92%
1か月 パフォーマンス:
+13.34%
6か月 パフォーマンス:
+68.32%
1年 パフォーマンス:
+103.01%
1日の値動き範囲:
$37.27
$38.50
1週間の範囲:
$35.04
$39.15
52週間の値動き範囲:
$14.00
$44.00
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Compare VTVT vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
37.72 | 150.97M | 17,000 | -31.08M | -24.86M | -3.3463 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-12 | 開始されました | Evercore ISI | Outperform |
| 2026-01-23 | 開始されました | Roth Capital | Buy |
| 2026-01-05 | 開始されました | TD Cowen | Buy |
| 2025-11-19 | 開始されました | BTIG Research | Buy |
| 2019-05-30 | 開始されました | H.C. Wainwright | Buy |
| 2018-04-10 | ダウングレード | Stifel | Buy → Hold |
| 2018-03-08 | 開始されました | ROTH Capital | Buy |
| 2018-02-08 | 開始されました | Northland Capital | Outperform |
| 2016-09-26 | 開始されました | H.C. Wainwright | Buy |
| 2015-09-04 | 開始されました | Canaccord Genuity | Buy |
| 2015-08-24 | 開始されました | Piper Jaffray | Overweight |
| 2015-08-24 | 開始されました | Stifel | Buy |
すべてを表示
Vtv Therapeutics Inc (VTVT) 最新ニュース
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Liquidity Mapping Around (VTVT) Price Events - Stock Traders Daily
BTIG reiterates Buy on vTv Therapeutics stock, keeps $49 target By Investing.com - Investing.com Canada
Sentiment Recap: Will vTv Therapeutics Inc outperform the market in YEAR2026 Sector Moves & Weekly Chart Analysis and Guides - baoquankhu1.vn
Investment Review: Will vTv Therapeutics Inc benefit from green energy policiesPortfolio Performance Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Published on: 2026-04-11 18:49:35 - baoquankhu1.vn
Market Leaders: Whats next for vTv Therapeutics Inc stock2026 Analyst Calls & Consistent Profit Alerts - baoquankhu1.vn
VTVT Technical Analysis | Trend, Signals & Chart Patterns | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill
Aug Shorts: Will vTv Therapeutics Inc face regulatory challengesDividend Hike & Weekly Market Pulse Updates - baoquankhu1.vn
VTV Therapeutics (VTVT) reports $27M 2025 net loss amid cadisegliatin advancements - MSN
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Sahm
New vTv hire gets 4,000 stock options priced at $39.54 - Stock Titan
VTVT Forecast, Price Target & Analyst Ratings | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill
Growth Recap: Will vTv Therapeutics Inc outperform the market in YEAR2026 Short Interest & Smart Money Movement Tracker - baoquankhu1.vn
We're Not Worried About VTv Therapeutics' (NASDAQ:VTVT) Cash Burn - Moomoo
We Think vTv Therapeutics (NASDAQ:VTVT) Can Easily Afford To Drive Business Growth - Sahm
Why (VTVT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet - sharewise.com
Millennium Management LLC Acquires Shares in vTv Therapeutics Inc - GuruFocus
VTVT Technical Analysis & Stock Price Forecast - Intellectia AI
Aug PostEarnings: How does vTv Therapeutics Inc score in quality rankingsStop Loss & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
vTv Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Analysts’ Opinions Are Mixed on These Healthcare Stocks: vTv Therapeutics (VTVT) and CSPC Pharmaceutical Group (OtherCHJTF) - The Globe and Mail
Millennium Management (NASDAQ: VTVT) reports a 5.0% holding in vTv - Stock Titan
Technical Analysis: Will vTv Therapeutics Inc outperform the market in YEAR2026 EndofMonth & Long Hold Capital Preservation Plans - baoquankhu1.vn
How CRH plc stock performs during market volatility - baoquankhu1.vn
Aug Action: Does vTv Therapeutics Inc have declining or rising EPSEarnings Recap Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
CEO Moves: Is vTv Therapeutics Inc exposed to currency risks2026 Key Highlights & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Understanding Momentum Shifts in (VTVT) - Stock Traders Daily
Guidance Update: Will vTv Therapeutics Inc benefit from green energy policiesInsider Selling & Real-Time Buy Zone Alerts - baoquankhu1.vn
Published on: 2026-03-23 05:09:08 - baoquankhu1.vn
vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements - Yahoo Finance
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade - Yahoo Finance
vTv Therapeutics to Participate in the 38th Annual ROTH Conference - The Manila Times
VTv Therapeutics to Participate in the 38th Annual ROTH Conference - marketscreener.com
Biotech developing oral type 1 diabetes drug joins ROTH investor event - Stock Titan
Baker BROS. Advisors LP Has $3.46 Million Holdings in vTv Therapeutics Inc. $VTVT - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Upgraded at Evercore - MarketBeat
Wall Street Zen Upgrades vTv Therapeutics (NASDAQ:VTVT) to "Hold" - MarketBeat
HC Wainwright Raises Earnings Estimates for vTv Therapeutics - Defense World
HC Wainwright Brokers Increase Earnings Estimates for VTVT - Defense World
HC Wainwright Forecasts Higher Earnings for vTv Therapeutics - MarketBeat
This Jabil Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Sahm
Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT) and Oxford BioMedica (OtherOXBDF) - The Globe and Mail
Evercore ISI initiates vTv Therapeutics stock with outperform rating By Investing.com - Investing.com Canada
Evercore ISI Initiates vTv Therapeutics at Outperform With $44 Price Target - marketscreener.com
Evercore ISI Initiates Coverage on VTVT with Outperform Rating | VTVT Stock News - GuruFocus
Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Sarepta Therapeutics (SRPT) and vTv Therapeutics (VTVT) - The Globe and Mail
Research Analysts Set Expectations for VTVT Q1 Earnings - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Share Price Crosses Below 50-Day Moving AverageShould You Sell? - MarketBeat
BTIG Maintains Buy on vTv Therapeutics Inc (VTVT) March 11, 2026 - Meyka
Vtv Therapeutics Inc (VTVT) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):